Suson, Josatan .

HRN: 16 83 94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/31/2023
08/06/2023
IV
800mg
Q6
T/C Sepsis, Pcap C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: